ECDC and EMA have issued a joint statement on adapted COVID-19 vaccines and considerations for their use during the upcoming autumn 2023 vaccination campaigns.
See all information on COVID-19, situation updates, risk assessments, questions and answers, latest evidence, surveillance and laboratory guidance and how to protect yourself and others.
The mpox (monkeypox) virus is transmitted to humans through a bite or direct contact with an infected animal’s blood, body fluids or cutaneous/mucosal lesions.
COVID-19 vaccines aim to prevent COVID-19 by triggering an immune response. Safe and effective COVID-19 vaccines are a powerful tool for controlling the pandemic.
EU/EEA countries are reporting an increased number of Escherichia coli (E. coli) isolates carrying the blaNDM-5 gene that makes them resistant to carbapenems, antibiotics.
Analysis of whole genome sequencing and epidemiological data of 874 E. coli isolates from the national collections of 13 countries confirmed the increase of E. coli isolates carrying blaNDM-5 which was previously detected in the CCRE survey.
Between 2018 and 2020, nearly 20 000 surgical site infections (SSIs) were reported from a total of over 1.2 million surgical procedures in 13 EU/EEA countries participating in ECDC-coordinated SSI surveillance. Over 2 500 hospitals are part of this surveillance network.